Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial

BMC Public Health

Volumn 17, Issue 1, 2017, Pages 1-12

  El Hajj, Maguy Saffouh ^a   Kheir, Nadir ^a   Al Mulla, Ahmad Mohd ^b   Shami, Rula ^a   Fanous, Nadia ^b   Mahfoud, Ziyad R ^c  

^a Qatar University ^*  (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Intervention; Pharmacist; Qatar; Randomized controlled trial; Smoking cessation; Tobacco cessation

Indexed keywords

ADULT; CONTROLLED STUDY; COUNSELING; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PHARMACIST; PREVENTION AND CONTROL; PROCEDURES; PROSPECTIVE STUDY; QATAR; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER;

ADULT; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PROSPECTIVE STUDIES; QATAR; SELF REPORT; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 85013392368     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-017-4103-4     Document Type: Article

References (48)

1. The World Health Organization. Tobacco factsheet. http://www.who.int/mediacentre/factsheets/fs339/en/. Accessed 2 Sept 2016.
2. The World Health Organization. Report on the Global Tobacco Epidemic, 2011:warning about the dangers of tobacco. http://apps.who.int/iris/bitstream/10665/44616/1/9789240687813_eng.pdf. (2011). Accessed 2 Sept 2016.
3. The World Health Organization. Fact sheet about health benefits of smoking cessation. http://www.who.int/tobacco/quitting/en_tfi_quitting_fact_sheet.pdf. (2015). Accessed 22 May 2016.
4. The World Health Organization. Tobacco Free Initiative (TFI). http://www.who.int/tobacco/research/cessation/en/. Accessed 22 May 2016.
5. U.S. Department of Health and Human Services. Treating tobacco use and dependence: 2008 update.2008. http://bphc.hrsa.gov/buckets/treatingtobacco.pdf. Accessed 22 May 2016.
6. Aquilino ML, Farris KB, Zillich AJ, Lowe JB. Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy. 2003;23:666-73.
7. Saba M, Diep J, Saini B, Dhippayom T. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther. 2014;39:240-7.
8. Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches: linking hospital to the community. J Pharm Pract Res. 2002;32:57-62.
9. Carroll P, Rois R, Sarson D, Flynn J. A community pharmacy based smoking cessation program using transdermal nicotine replacement therapy: actions and outcomes. Aust Pharmacist. 2000;19:51-5.
10. Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002;22:759-65.
11. Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43:194-201.
12. Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995;NS35:20-9.
13. Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:51-6.
14. Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc. 2004;44:700-15.
15. The International Pharmaceutical Federation. FIP Statement of Policy: the Role of the Pharmacist in Promoting a Tobacco Free Future. https://www.fip.org/files/fip/news/tobacco-final2.pdf (2003). Accessed 22 May 2016.
16. Europharm Forum. Pharmacists and Actions on Tobacco. http://apps.who.int/iris/bitstream/10665/108128/1/E61288.pdf (1998). Accessed 22 May 2016.
17. Hudmon KS, Corelli RL. ASHP therapeutic position statement on the cessation of tobacco Use. Am J Health Syst Pharm. 2009;66:291-307.
18. The World Health Organization. Global Adult Tobacco Survey Qatar. http://www.emro.who.int/images/stories/tfi/documents/FACT_SHEETS/FS_GATS_Qatar_2013.pdf?ua=1 (2013). Accessed 22 May 2016.
19. The World Health Organization. Global Youth Tobacco Survey Qatar. http://www.nhsq.info/app/media/1598 (2014). Accessed 22 May 2016.
20. The World Health Organization. Qatar: WHO Statistical Profile. http://www.who.int/gho/countries/qat.pdf?ua=1 (2015). Accessed 22 May 2016.
21. Bener A, Ayub H, Kakil R, Ibrahim W. Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev. 2008;9:19-24.
22. Smoking - Addressing a National Epidemic. Available at: https://qatar-weill.cornell.edu/media/intoHealth/SmokingEpidemic.html. Accessed 22 May 2016.
23. Supreme Council of Health. TOBACCO CESSATION ACTION PLAN: (2015-2016). https://www.moph.gov.qa/app/media/3562 . Accessed 22 May 2016.
24. El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34:667-76.
25. El Hajj MS, Kheir N, Al Mulla AM, Al-Badriyeh D, Al Kaddour A, Mahfoud ZR, et al. Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial. Trials. 2015;16:65.
26. UpToDate. Behavioral approaches to smoking cessation. http://www.uptodate.com/contents/behavioral-approaches-to-smoking-cessation. Accessed 22 May 2016.
27. Kennedy DT, Small RE. Development and implementation of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:83-92.
28. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86:1119-27.
29. Al Mohamed HI, Amin TT. Pattern and prevalence of smoking among students at King Faisal University, Al Hassa. Saudi Arabia EMHJ. 2010;16:56-64.
30. Asfar MD, Vander MW, Maziak W, Hammal F, Eissenberg T, Ward KD. Outcomes and adherence in Syria’s first smoking cessation trial. Am J Health Behav. 2008;32:146-56.
31. Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health Syst Pharm. 1995;52:282-7.
32. DRUGDEX® Evaluations. Nicotine. http://www.micromedexsolutions.com/home/dispatch. Accessed 22 May 2016.
33. DRUGDEX® Evaluations: Nicotine polacrilex. http://www.micromedexsolutions.com/home/dispatch. Accessed 22 May 2016.
34. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163:1693-722.
35. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
36. Borelli B, Hogan J, Bock B, Pinto B, Roberts M, Marcus B. Predictors of quitting and dropout among women in a clinic-based smoking cessation program. Psychol Addict Behav. 2002;16:22-7.
37. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96:325-31.
38. Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomized controlled trial in Scotland. Tob Control. 1998;7:253-61.
39. Thomas D, Abramson MJ, Bonevski B, Taylor S, Poole SG, Paul E, et al. Integrating smoking cessation into routine care in hospitals-a randomized controlled trial. Addiction. 2016;111:714-23.
40. El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38:330-43.
41. Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106:2110-21.
42. Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, et al. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res. 2011;13:135-45.
43. Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy. 2001;21:636-41.
44. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004;6 Suppl 3:S363-9.
45. Khan N, Anderson JR, Du J, Tinker D, Bachyrycz AM, Namdar R. Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico. Ann Pharmacother. 2012;46:1198-204.
46. Shen X, Bachyrycz A, Anderson JR, Tinker D, Raisch DW. Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico. J Manag Care Spec Pharm. 2014;20:579-87.
47. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;5:CD000165.
48. Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol Biomarkers Prev. 2004;13:2012-22.